Immix Biopharma (IMMX) Operating Leases (2024 - 2026)
Immix Biopharma (IMMX) posted Operating Leases of $912343.0 for Q1 2026, down 2.28% sequentially from $933625.0 in Q4 2025, and down 7.95% YoY from $991126.0 in Q1 2025.
Immix Biopharma (IMMX) Operating Leases (2024 - 2026) Analysis & Trends
Immix Biopharma has reported Operating Leases for 3 years, with the latest figure at $912343.0 in Q1 2026.
- Quarterly Operating Leases fell 7.95% year-over-year to $912343.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $912343.0 (down 7.95% YoY) and the FY2025 annual result came in at $933625.0, down 7.52% from the prior year.
- Operating Leases fell to $912343.0 in Q1 2026 per IMMX's latest filing, from $933625.0 in the prior quarter.
- Over five years, Operating Leases peaked at $1.1 million in Q1 2024 and troughed at $912343.0 in Q1 2026.
- A 3-year average of $990235.6 and a median of $991126.0 in 2025 frame the typical range for Operating Leases.
- The sharpest annual moves came in 2025 and 2026: Operating Leases dropped 5.97% in 2025, then slipped 7.95% in 2026.
- Over 3 years, Operating Leases stood at $1.0 million in 2024, then dropped by 7.52% to $933625.0 in 2025, then slipped by 2.28% to $912343.0 in 2026.
- According to Business Quant data, Operating Leases over the past three periods registered $912343.0, $933625.0, and $965053.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Immix Biopharma | 784.75 Mn | 784.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 890,638.00 |
| Mar 31, 2026 | 912,343.00 |
| Dec 31, 2025 | 933,625.00 |
| Sep 30, 2025 | 965,053.00 |
| Jun 30, 2025 | 972,335.00 |
| Mar 31, 2025 | 991,126.00 |
| Dec 31, 2024 | 1.01 Mn |
| Sep 30, 2024 | 1.03 Mn |
| Jun 30, 2024 | 1.04 Mn |
| Mar 31, 2024 | 1.06 Mn |